Skip to Main Content

Please be wary of fraudsters who may attempt to impersonate Cambridge Associates employees. Recently, reports have increased of scams that start with unsolicited invitations to join WhatsApp groups for sharing investment strategies or “stock tips.” Cambridge Associates does not participate in such activities. Avoid sharing personal details or conducting sales with unverified individuals. Report incidents to local authorities and the website owner. WhatsApp scammers may be reported here. For additional information, click here.

Chris Seiter

Chief Corporate Finance Officer, RTW Investments

Chris provides structuring and transactional leadership for new ventures originated at RTW as well as royalty and alternative investments. Chris also provides oversight and support to the financial operations and business development of the newly formed ventures.

Prior to joining RTW, Chris served as Chief Financial Officer of two development stage biopharmaceutical companies, Trevi Therapeutics and Millendo Therapeutics. Before shifting to an operational role, Chris served as Managing Director and Head of Life Sciences Investment Banking at Bank of America Merrill Lynch where he focused on advising life sciences companies on transactions ranging from equity and debt financings to mergers and acquisitions. Chris served in the Navy as a Nuclear Submarine Officer for five years before beginning his investment banking career.

Chris received a BA in economics cum laude from the University of Rochester and completed a graduate level program in nuclear engineering at the U.S. Naval Nuclear Power School.